Gold nanoparticles (GNPs) have garnered significant attention in biomedical applications, particularly as versatile platforms for drug delivery and targeted therapy. The conjugation of GNPs with antibodies offers a promising strategy to enhance their specificity and efficacy in various therapeutic approaches. In this study, we focus on synthesizing different types of GNPs conjugated with antibodies and investigate the influence of various synthesis methods on nanoparticle characterization. The results demonstrated that different synthesis methods lead to different degrees of antibody conjugation on the GNP surface and to varied efficiency on biosystems. This work has the potential to outline design principles that could positively affect the development of targeted nanotherapeutics for various biomedical applications.
No takes yet. Share an insight, caveat, or question.
Anaki et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: